Smart Pills Market Is currently worth USD 1,800 million. Furthermore, the market is expected to demonstrate a robust CAGR of 14.2% during the forecast period (2018–2023).
The smart pills are mostly found in the form of a vitamin capsule sized pill, containing a small wearable sensor patch, in addition to an application on mobiles as well as a provider portal. After swallowing a smart pill, its activation in the gut occurs; after which the sensors offer information with regard to the patient’s health parameters coupled with the effectiveness of the treatment.
Smart Pills Market Segmentation
The worldwide smart pills market is segmented based on application, target area, disease indication, and end-user.
With respect to the application
, the market has been segmented into capsule endoscopy, drug delivery, patient monitoring, and others. The types of capsule endoscopy are small bowel capsule endoscopy, controllable capsule endoscopy, colon capsule endoscopy, and others. The types of patient monitoring include capsule pH monitoring and others.
depending on the target area
, has been categorized into esophagus, small intestine, large intestine, and stomach.
The disease indication section
has been considered for esophageal diseases, small bowel diseases, colon diseases, and others.
The end-users covered
by the report are hospitals, diagnostic center, and research institute.
The leading companies within the worldwide smart pills market include,
- CapsoVision Inc.
- FUJIFILM Holdings Corporation
- Proteus Digital Health Inc.
- Olympus Corporation
- BDD Limited
- JINSHAN Science & Technology
- PENTAX Medical
- RF Co. Ltd.
- among others.
Browse Complete Premium Research Page along with Detailed TOC@
At Market Research Future (MRFR):
Market Research Future
+1 646 845 9312
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.